Sue Wall Street digs into the scams, cover-ups, and corporate faceplants that Wall Street hopes you’ll ignore. From fraud and insider trading to the whistleblowers who called it out we break down how the powerful play the game and sometimes get burned. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Go to ZLK.com for more on the case and follow us for the next corporate faceplant.
All content for SueWallSt is the property of SueWallSt and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Sue Wall Street digs into the scams, cover-ups, and corporate faceplants that Wall Street hopes you’ll ignore. From fraud and insider trading to the whistleblowers who called it out we break down how the powerful play the game and sometimes get burned. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Go to ZLK.com for more on the case and follow us for the next corporate faceplant.
When Sable Offshore $SOC announced its oil production had resumed, investors rushed in—and the stock jumped 14%. But the truth? No real restart, just well testing. In this episode of Sue Wall Street, Cassie and Bill uncover how one press release, one $295M secondary offering, and one harsh reality check triggered a class action lawsuit. Perfect for investors, analysts, and compliance pros, this episode blends sharp commentary with deep legal insight.
Add our WhatsApp Channel.
Visit ZLK.com for more info.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.
SueWallSt
Sue Wall Street digs into the scams, cover-ups, and corporate faceplants that Wall Street hopes you’ll ignore. From fraud and insider trading to the whistleblowers who called it out we break down how the powerful play the game and sometimes get burned. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Go to ZLK.com for more on the case and follow us for the next corporate faceplant.
